Amanote Research

Amanote Research

    RegisterSign In

Tackling Burkitt Lymphoma in Older Patients: Novel Strategies and the Promise of Targeted Agents

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2012.739689
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncologyHematology
Date

January 2, 2013

Authors
Catherine LaiKieron Dunleavy
Publisher

Informa UK Limited


Related search

MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

Cancer Research
Cancer ResearchOncology
2019English

Novel Targeted Strategies to Overcome Microenvironment-Dependent Resistance in Mantle Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Burkitt Lymphoma

British Journal of Haematology
Hematology
2017English

Status and Prognostic Nomogram of Patients With Burkitt Lymphoma

Oncology Letters
Cancer ResearchOncology
2019English

Denis Burkitt and the African Lymphoma

ecancermedicalscience
Cancer ResearchOncology
2010English

Cytology and Histochemistry of the Burkitt Lymphoma

British Journal of Cancer
Cancer ResearchOncology
1963English

The Mutational Landscape of Burkitt-Like Lymphoma With 11q Aberration Is Distinct From That of Burkitt Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Burkitt Lymphoma With Multiorgan Involvement

International Journal of Recent Surgical and Medical Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy